These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 564256)

  • 1. Tricyclic antidepressant drugs: antagonism of effect of D-lysergic acid diethylamide (LSD) on shock elicited aggression.
    Sheard M; Astrachan D; Davis M
    Commun Psychopharmacol; 1977; 1(2):167-73. PubMed ID: 564256
    [No Abstract]   [Full Text] [Related]  

  • 2. Tricyclic antidepressant drugs: attenuation of excitatory effects of d-lysergic acid diethylamide (LSD) on acoustic startle response.
    Davis M; Gallager DW; Aghamanian GK
    Life Sci; 1977 Apr; 20(7):1249-57. PubMed ID: 850475
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of chronic treatment with tricyclic antidepressant drugs on identified brain noradrenergic and serotonergic neurons.
    Svensson TH
    Acta Psychiatr Scand Suppl; 1980; 280():121-31. PubMed ID: 6250320
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of D-lysergic acid diethylamide (LSD) upon shock elicited fighting in rats.
    Sheard MH; Astrachan DI; Davis M
    Life Sci; 1977 Feb; 20(3):427-30. PubMed ID: 557157
    [No Abstract]   [Full Text] [Related]  

  • 5. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the role of serotonin in lithium action using shock-elicited fighting.
    Marini JL; Sheard MH; Kosten T
    Commun Psychopharmacol; 1979; 3(4):225-33. PubMed ID: 93531
    [No Abstract]   [Full Text] [Related]  

  • 7. Norepinephrine metabolism after short- and long-term administration of tricyclic antidepressant drugs and electroconvulsive shock.
    Schildkraut JJ
    Adv Biochem Psychopharmacol; 1975; 13():137-53. PubMed ID: 1155232
    [No Abstract]   [Full Text] [Related]  

  • 8. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of behavioral effects of electroconvulsive shock but not those of desipramine by the selective 5-HT-3 receptor antagonist, ondansetron.
    Kostowski W; Płaźnik A; Nazar M; Jessa M
    Pol J Pharmacol; 1995; 47(2):193-5. PubMed ID: 8688895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of responses to adrenergic nerve stimulation in isolated rat atria during chronic tricyclic antidepressant administration.
    Crews FT; Smith CB
    J Pharmacol Exp Ther; 1980 Oct; 215(1):143-9. PubMed ID: 6256516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of tricyclic antidepressants on performance under a differential-reinforcement-of-low-rates schedule in rats.
    McGuire PS; Seiden LS
    J Pharmacol Exp Ther; 1980 Sep; 214(3):635-41. PubMed ID: 7400965
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitated shock-induced aggression after chronic treatment with antidepressant drugs in the rat.
    Mogilnicka E; Przewłocka B
    Pharmacol Biochem Behav; 1981 Feb; 14(2):129-32. PubMed ID: 7193878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of chronic desipramine on shock-elicited fighting in rats.
    Prasad V; Sheard MH
    Agressologie; 1983 Jan; 24(1):15-7. PubMed ID: 6683471
    [No Abstract]   [Full Text] [Related]  

  • 15. A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.
    Colpaert FC; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):206-14. PubMed ID: 7062283
    [No Abstract]   [Full Text] [Related]  

  • 16. Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test).
    Consoli D; Fedotova J; Micale V; Sapronov NS; Drago F
    Eur J Pharmacol; 2005 Sep; 520(1-3):100-7. PubMed ID: 16150440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

  • 18. LSD-accentuated individual type of social behavior in mice.
    Krsiak M; Borgesovã M; Kadlecovã O
    Act Nerv Super (Praha); 1971; 13(3):211-2. PubMed ID: 5166181
    [No Abstract]   [Full Text] [Related]  

  • 19. Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium.
    Bonson KR; Murphy DL
    Behav Brain Res; 1996; 73(1-2):229-33. PubMed ID: 8788508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus properties of lysergic acid diethylamide in the monkey.
    Nielsen EB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):244-9. PubMed ID: 4009503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.